{
  "cik": 2011514,
  "cik_padded": "0002011514",
  "entityName": "Anteris Technologies Global Corp.",
  "fiscal_years": [
    {
      "accn": "0001140361-26-006977",
      "filed": "2026-02-26",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1954000.0,
        "eps_diluted": -2.55,
        "free_cash_flow": -79757000.0,
        "net_income": -94144000.0,
        "operating_cash_flow": -77803000.0,
        "operating_income": -93894000.0,
        "revenue": 1913000.0,
        "stockholders_equity": -93000.0,
        "total_assets": 22997000.0,
        "total_liabilities": 23250000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "revenue_growth_yoy": -0.292267850536441,
        "roa_avg2y": -1.8157691714241628,
        "roe_avg2y": -3.0045318184719476
      }
    },
    {
      "accn": "0001140361-26-006977",
      "filed": "2026-02-26",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2266000.0,
        "eps_diluted": -3.68,
        "free_cash_flow": -63507000.0,
        "net_income": -76291000.0,
        "operating_cash_flow": -61241000.0,
        "operating_income": -78372000.0,
        "revenue": 2703000.0,
        "stockholders_equity": 62761000.0,
        "total_assets": 80699000.0,
        "total_liabilities": 18017000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_period_end": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.28707318239033797,
        "roa_period_end": -0.9453772661371268,
        "roe_period_end": -1.2155797390098946
      }
    }
  ],
  "latest_filing": {
    "accn": "0001140361-26-006977",
    "filed": "2026-02-26",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "3842",
  "sic_description": "Orthopedic, Prosthetic & Surgical Appliances & Supplies",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0002011514.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0002011514.json"
  },
  "ticker": "AVR"
}